R&D Platform
Technology Platforms · IP · Collaboration Models
Technology Platforms
Microbial and pathogen research platform
Microbial isolation and identification, pathogen biology, and anti infection evaluation system.
Drug molecule and formulation research and development platform
Screening of lead compounds, molecular optimization, and development of formulation processes.
Vaccine construction and immune evaluation platform
Construction of novel antigens, adjuvant systems, and preclinical immune evaluation.
Functional Food Active Substance Evaluation Platform
Screening, formulation development, and safety evaluation of active ingredients from medicinal and edible sources.
Intellectual Property
Patent portfolio covering drug molecules, vaccine technologies and functional formulas, open for technology transfer and licensing.
A lead compound for anti infection and its preparation method
New antigen design delivery system
Functional formula and stability process of medicinal food homology
Microbial nutrition evaluation method
Partnership Models
Joint R&D
Shared investment, shared outcomes
Contract Research
We deliver your R&D programmes
Technology Licensing
Patent and technology transfer
Industrialisation
Manufacturing, registration and market access
R&D Pipeline
Focused on unmet clinical and health needs, advancing each candidate steadily.
🧪Innovative Drugs
GLB-001GLB-001 Anti-infective Candidate
Novel anti-MDR small molecule; key efficacy studies completed.
GLB-002GLB-002 Metabolic-inflammatory Modulator
Lead optimisation targeting metabolic-inflammatory pathways.
💉Vaccines
GLV-101GLV-101 Novel Antigen Vaccine
Antigen design completed; IND filing in progress.
GLV-102GLV-102 Adjuvant Platform
Broad-spectrum adjuvant system construction and evaluation.
🌿Functional Food & Health Products
GLF-201GLF-201 Function Formula
First functional dietary product launched in GBA market.
GLF-202GLF-202 Microbiome Nutrition Series
Formulation finalised; scale-up and registration ongoing.